Professional Documents
Culture Documents
OUTPATIENT MANAGEMENT
Acute respiratory tract infections are the most common illnesses in childhood,
comprising as many as 50% of all illnesses in children less than 5 years old and 30% in
children aged 5 – 12 years. Multiple factors determine the frequency and nature of
these illnesses. These include host factors, environmental factors and infecting agents.
The common acute respiratory tract infections will be individually discussed,
highlighting the diagnostic features and current management guidelines.
Contents
• Classification of acute respiratory tract infections
• Clinical features
• Common pathogens
• Clinical course
• Management guidelines
• Issues encountered in family practice
1
Bulletin 10; August 1999
Classification Clinical features
2
Bulletin 10; August 1999
Classification Clinical features
Epiglottitis Uncommon in our local population. Most common between 3-4 years old.
May have preceding URTI. Acute onset with rapid progression within 3-4
hours
• Fever, ill, lethargic
• Voice and dry muffled
• Refusal to eat or drink
• Drooling of saliva
• May have inspiratory stridor
• Cough is usually not a prominent feature
Acute Bronchiolitis Affects children < 24 mths old, mainly between 1 to 6 months of age.
Usually preceded by upper respiratory tract symptoms
• Fever
• Cough
• Respiratory distress
• Wheezing and
• Difficulty feeding
Chest hyperinflation with subcostal retractions, fine crackles, + rhonchi.
Young infants (especially premature babies) may present with apnea.
Cyanosis may occur in severe cases.
Pneumonia • Fever
• Cough
• Tachypnea
• Constitutional symptoms.
• Crackles
• Signs of consolidation
3
Bulletin 10; August 1999
Classification Common Pathogens Clinical Course
Acute Infective • >90% are viral (Rhinovirus, • Symptoms last 1-2 days but may
Rhinitis (the Common adenovirus, RSV, parainfluenza, persist up to 1 –2 weeks.
Cold) influenza viruses) • Nasal discharge may continue,
• Occasionally bacterial agents becoming mucopurulent or
include: Streptococcus purulent.
pneumoniae, Hemophilus
influenzae, Moraxella catarrhalis
4
Bulletin 10; August 1999
Classification Common Pathogens Clinical Course
Acute Bronchiolitis • Respiratory syncytial virus (RSV) • Most infants recover within a
predominant cause. Other viruses week and 10 days
eg parainfluenzae virus • Some may have persistent cough
occasionally responsible. for up to 3 weeks.
• Bacterial superinfection is
uncommon.
• The latter should be suspected if:
o Fever > 1week
o Prolonged symptoms > 1 week
o Elevated total white cell count
o And CXR showing consolidation
5
Bulletin 10; August 1999
Classification Management guidelines Important notes
Acute Infective • Use of antibiotics has no significant • In very young babies who are obligate
Rhinitis (the Common benefit and may cause side-effects. nose breathers, nasal obstruction may
Cold) • Presence of mucopurulent rhinitis is impair feeding.
not an indication for antibiotic • Hospitalization may be necessary if
therapy. child is unable to feed.
• Symptomatic treatment: paracetamol,
topical vasoconstrictor nasal drops.
• Antihistamines or pseudoephedrine
not shown to be beneficial.
Otitis Media • Amoxycillin is 1st line antibiotic. • Children under the age of 2 yrs are at
• In patients who are penicillin-allergic, higher risk of developing recurrent
trimethoprim-sulphasoxazole is the episodes, chronic otitis media and
drug of choice. serious septic complications.
• Second line antibiotics include
amoxycillin/clavulanate,
ampicillin/salbactam or a
cephalosporin
Acute Sinusitis • Amoxycillin is 1st line antibiotic • Antibiotics useful because of majority
• If allergic to penicillin, trimethoprim- are bacterial
sulphamethoxazole is the drug of • 2nd line antibiotic if no response by 72
choice. hours of therapy
• 2nd line:amoxycillin/clavulanate , • duration of therapy 7 to 10 days
ampicillin/salbactam, or • if patient better but still symptomatic by
cephalosporin. 10 days, continuation of antibiotics for
• Symptomatic: decongestants. another 7 days is recommended
• surgical drainage rarely needed in
children.
6
Bulletin 10; August 1999
Classification Management guidelines Important notes
Pneumonia • Amoxycillin is the antibiotic of first • Although viruses are major causes of
choice. pneumonia in infants and young
• Macrolides if Mycoplasma suspected. children, there is no simple and rapid
• Macrolides can also be used if method to distinguish viral from
Penicillin allergic bacterial infection and mixed infection
• 2nd line antibiotics is not uncommon.
:Amoxycillin/clavulanate, • Pneumonia should always be
Ampicillin/Sulbactam, Cephalosporin. considered potentially bacterial and
patient treated with antibiotics.
• High risk antibiotic resistance:
• Child-care-going child
• Recent antibiotic use
7
Bulletin 10; August 1999
Issues frequently encountered in family practice
a. URTIs account for a high proportion of clinic visits to the family practitioner. Children
younger than 5 years of age experience 3 to 8 episodes of URTI per year. The frequency
may be as high as once a month especially if the child is attending school, day-care or
has a sibling attending school. Importantly, most these episodes are minor, short-lived
and self-limiting colds or sorethroats. The child should also be symptomatically well
between episodes and growing satisfactorily.
b. The peak incidence for LRTIs is in the first year of life after which the incidence falls
progressively throughout childhood.
The majority of URTIs are caused by viruses. Hence antibiotics are not usually necessary.
In fact meta-analysis of randomised clinical trials have failed to demonstrate that antibiotics
prevent LRTI. The issue of increasing resistant strains of bacteria is becoming an alarming
problem worldwide. Specific indications for antibiotics are summarized under the
management section.
8
Bulletin 10; August 1999
Acute Respiratory Tract Infections in Children:
Overall Management Algorithm
NO YES
Determine: Determine:
Otitis Media Epiglottitis
Sinusitis ALTB
Pharyngitis/tonsillitis Bronchitis
Rhinitis Bronchiolitis
Pneumonia
9
Bulletin 10; August 1999